Skip to main content
. 2018 Jan 31;8(3):181–186. doi: 10.1016/j.jpha.2018.01.004

Fig. 2.

Fig. 2

FT-IR analysis of (a) phenylbutazone, (b) AL-1 FP, (c) XDP 3150, and (d) XDP 3050 silicas prior to formulation.